SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-016487
Filing Date
2023-06-26
Accepted
2023-06-26 16:05:29
Documents
2
Period of Report
2023-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5840
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3571
  Complete submission text file 0000899243-23-016487.txt   11680
Mailing Address 6-8 DOSHOMACHI 2-CHOME CHUO-KU OSAKA M0 541-0045
Business Address 6-8 DOSHOMACHI 2-CHOME CHUO-KU OSAKA M0 541-0045 816-6203-5321
Sumitomo Pharma Co., Ltd. (Reporting) CIK: 0001446601 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 231042372

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Issuer) CIK: 0001635088 (see all company filings)

IRS No.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020
Business Address 7-1, NIHONBASHI 2-CHOME CHUO-KU TOKYO M0 103-6020 813-5201-0222
Sumitomo Chemical Co., Ltd. (Reporting) CIK: 0001798550 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 0331
Type: 4 | Act: 34 | File No.: 001-40782 | Film No.: 231042373